Search
for
Sort by
Research 331–360 of 1000+
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Topical use of systemic drugs in dermatology: A comprehensive review
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Pharmacology of antiandrogens
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- Potential adverse effects of long-term testosterone therapy
- Prostate Cancer Early Detection, Version 2.2015
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- Cellular senescence in tissue repair: every cloud has a silver lining
- Finasteride-its impact on sexual function and prostate cancer
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Therapeutic Androgen Receptor Ligands
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Nocebo effect in Dermatology
- 25 years of ERβ: a personal journey
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine